Acute Hemolysis Due to Rh Antibodies Against C and e Antigens after Rh-incompatible Transfusion in a Patient, Not Detected During Pre-transfusion Testing
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Pre-transfusion laboratory tests include ABO and RhD typing, antibody screening test, antibody identification test, and cross-matching. The objective of pre-transfusion testing is to ensure that serologically compatible blood products are administered to patients, thus preventing transfusion complications. Rhesus (Rh) system is considered the second most important after the ABO system, as Rh antigens are highly immunogenic and anti-Rh antibodies can cause hemolytic transfusion reactions (HTR) and hemolytic disease of the fetus and newborn. HTR caused by anti-Rh antibody usually results in delayed onset HTR. There is little information on whether antibodies against C and e antigen can elicit acute hemolytic transfusion reaction. We present here, a rare case of acute hemolytic transfusion reaction caused due to antibodies against C and e antigens, which were not detected during our pre-transfusion protocol.
Abstract
Pre-transfusion laboratory tests include ABO and RhD typing, antibody screening test, antibody identification test, and cross-matching. The objective of pre-transfusion testing is to ensure that serologically compatible blood products are administered to patients, thus preventing transfusion complications. Rhesus (Rh) system is considered the second most important after the ABO system, as Rh antigens are highly immunogenic and anti-Rh antibodies can cause hemolytic transfusion reactions (HTR) and hemolytic disease of the fetus and newborn. HTR caused by anti-Rh antibody usually results in delayed onset HTR. There is little information on whether antibodies against C and e antigen can elicit acute hemolytic transfusion reaction. We present here, a rare case of acute hemolytic transfusion reaction caused due to antibodies against C and e antigens, which were not detected during our pre-transfusion protocol.
참고문헌 (30)
- Panch SR, "Hemolytic transfusion reactions", N Engl J Med, 381, pp.150~162 (2019)
- Strobel E, "Hemolytic transfusion reactions", Transfus Med Hemother, 35, pp.346~353 (2008)
- "National Healthcare Safety Network biovigilance component, hemovigilance module, surveillance protocol v2.5.2"[URL]
- Smith D, "Acute hemolytic transfusion reaction due to Anti-P1 : A case report and review of institutional experience", Transfus Med Hemother, 46, pp.380~383 (2019)
- Xu Z, "AntiAnWj causing acute hemolytic transfusion reactions in a patient with aplastic anemia", Transfusion, 52, pp.1476~1481 (2012)
- Michalewska B, "Acute haemolytic transfusion reaction apparently caused by the ‘enzyme-only’ anti-E", Vox Sang, 89, pp.61~ (2005)
- Ahn A, "Acute hemolytic transfusion reaction due to the"Anti-E"rhesus antibody in a patient with Crohn’s disease", Clin Lab, 65 (2019)
- Shmookler A, "Acute hemolytic transfusion reaction caused by a red cell antibody that was missed by pretransfusion testing using tube method", Lab Med, 48, pp.258~261 (2017)
- Pradhan D, "Acute intravascular haemolytic transfusion reaction due to anti-c undetected by conventional pretransfusion cross-matching tests", Am J Hematol, 61, pp.82~83 (1999)
- Lin CK, "Hemolytic transfusion reaction due to Rh antibodies detectable only by manual polybrene and polyethylene glycol technique", Am J Clin Pathol, 104, pp.660~662 (1995)
- Molthan L, "An immediate hemolytic transfusion reaction due to anti-C and a delayed hemolytic transfusion reaction due to anti-Ce+e : hemoglobinemia, hemoglobinuria and transient impaired renal function", Vox Sang, 47, pp.348~353 (1984)
- Nardozza LM, "The molecular basis of RH system and its applications in obstetrics and transfusion medicine", Rev Assoc Med Bras (1992), 56, pp.724~728 (2010)
- Sharma D, "Combined anti e and anti C Rh isoimmunisation and severe hyperbilirubinemia", Indian J Pediatr, 82, pp.570~ (2015)
- Sharma D, "Neonatal hyperbilirubinemia secondary to combined anti e and anti C isoimmunisation : a literature review", J Matern Fetal Neonatal Med, 32, pp.2009~2011 (2019)
- Ranasinghe E, "Anti-Ce complicating two consecutive pregnancies with increasing severity of haemolytic disease of the newborn", Transfus Med, 13, pp.53~55 (2003)
- Wagner T, "Severe HDN due to anti-Ce that required exchange tranfusion", Transfusion, 40, pp.571~574 (2000)
- Malde R, "Haemolytic disease of the newborn due to anti-Ce", Transfus Med, 10, pp.305~306 (2000)
- Makarovska-Bojadzieva T, "The impact of extended typing on red blood cell alloimmunization in transfused patients", Open Access Maced J Med Sci, 5, pp.107~111 (2017)
- 신정환, "Screening and Identification of Unexpected Red Cell Antibodies by Simultaneous LISS", Coombs and NaCl, Journal of Korean Medical Science, pp.2009, 24(4)[DOI]
- Hoppe B, "Acute haemolytic transfusion reactions due to weak antibodies that in vitro did not seem to be clinically significant", Vox Sang, 82, pp.207~210 (2002)
- Alizadeh D, "Chemotherapeutic targeting of cancerinduced immunosuppressive cells", Cancer Res, 74, pp.2663~2668 (2014)
- Florea AM, "Cisplatin as an anti-tumor drug : cellular mechanisms of activity, drug resistance and induced side effects", Cancers(Basel), 3, pp.1351~1371 (2011)
- Maloisel F, "Platin salts-induced hemolytic anemia : cisplatin-and the first case of carboplatin-induced hemolysis", Anticancer Drugs, 6, pp.324~326 (1995)
- Hendrickson JE, "Recipient factors infiuencing red blood cell alloimmunization", ISBT Science Series, 15, pp.194~200 (2020)
- Bauer MP, "Clinical predictors of alloimmunization after red blood cell transfusion", Transfusion, 47, pp.2066~2071 (2007)
- Körmöczi GF, "Responder individuality in red blood cell alloimmunization", Transfus Med Hemother, 41, pp.446~451 (2014)
- Singer ST, "Alloimmunization and erythrocyte autoimmunization in transfusion-dependent thalassemia patients of predominantly Asian descent", Blood, 96, pp.3369~3373 (2000)
- Lasalle-Williams M, "Extended red blood cell antigen matching for transfusions in sickle cell disease : a review of a 14-year experience from a single center(CME)", Transfusion, 51, pp.1732~1739 (2011)
- Killick SB, "Guidelines for the diagnosis and management of adult myelodysplastic syndromes", Br J Haematol, 164, pp.503~525 (2014)
- Cooling L, "Henry’s clinical diagnosis and management by laboratory methods", pp.726~ (2017), Elsevier
